Skip to main content

Advertisement

Table 2 Relative intensity of the four peptides in MM different groups and healthy control

From: Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma

Peaks (Da) ND group (n = 62)a HC group (n = 64) CR&VGPR group (n = 38) RR group (n = 43)
2660.65 47.73 ± 28.41 24.58 ± 11.3 26.73 ± 12.43 46.37 ± 27.54
2900.4 4.96 ± 2.12 1.31 ± 0.35 1.44 ± 0.38 5.08 ± 2.58
3315.96 7.48 ± 5.08 2.08 ± 1.16 1.94 ± 0.65 8.55 ± 5.78
7763.24 2.09 ± 1.69 8.86 ± 3.25 7.63 ± 2.01 1.91 ± 1.25
  1. a“n” stands for the number of patients